Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.50    -0.50 (-1.11%)
Bid:
44.00
Ask:
45.00
Spread: 1.00 (2.273%)
Market Cap: £85.38m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Q3 2018 Update

10 Oct 2018 07:00

RNS Number : 4852D
Iofina PLC
10 October 2018
 
 

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

Q3 2018 Update

Record Quarterly Iodine Production Since Company Inception

 

Iofina, specialists in the exploration and production of iodine and halogen-based specialty chemical derivatives, today provides an update to the market regarding its activities during the third quarter ("Q3" or the "Period") of 2018.

 

During the Period, the Company produced the largest quarterly total of crystalline iodine in the history of the organisation, producing a total of 172.3 metric tonnes ("MT") of crystalline iodine from its four operating IOsorb® plants in Oklahoma. This was an increase of 37.8 per cent from the prior year (Q3 2017: 125 MT). This record production reflected a full quarter of strong performance at the new IO#7 plant, as well as continued consistent operation of our mature IOsorb® plants.

 

The Directors anticipate that this positive momentum will continue as the Company moves into the fourth quarter and the winter months. The Directors also remain confident that the Company will achieve the 2018 forecast total of 575-605 MT of crystalline iodine. Iofina's current total of 436.4 MT of produced crystalline iodine through September positions the Company well to significantly surpass 2017 totals (FY 2017: 503 MT). 

 

Commenting, President and CEO Dr. Tom Becker, stated: 

"I am proud of the record quarterly production that has been achieved in the history of Iofina, in the third quarter this year. The execution of the Company's growth strategy, in particular the advantageous location of IO#7, and the performance of the operations team, continues to pay off for the Company and its stakeholders.

 

"Iofina Chemical continues to trade well and is exploring additional revenue streams. Not only have we been marketing the Company's IOflo® crystalline iodine, but also its other chemical products.

 

"As recently stated in our interim results, announced on 20th September 2018, production and profitability continue to move in a positive direction. Debt restructure and growth in 2019 remain the top priority for myself and the management team as we move towards the end of 2018. We expect the positive momentum we are currently achieving to significantly increase the Group's revenues and profits versus the first half of this year."

 

Enquiries:

 

Iofina plc

Dr. Tom Becker, CEO & President

Tel: +44 (0)20 3006 3135

www.iofina.com

 

finnCap Ltd

Christopher Raggett/Anthony Adams/Camille Gochez

Tel: +44 (0)20 7220 0500

 

Media Contact:

Yellow Jersey

Charles Goodwin/Harriet Jackson

Tel: +44 (0)7544 275 882

 About Iofina:

Iofina specialises in the exploration and production of iodine, halogen based specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America, based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Kentucky and Oklahoma. It is a vertically integrated company, covering the process from the production of iodine in the field, to the manufacture of the chemical end-products derived from iodine, supplying them to the consumer, and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilises its portfolio of patented and patent-pending technology, and proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFBVBFLFBV
Date   Source Headline
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
22nd Sep 20219:58 amRNSHolding(s) in Company
10th Sep 20214:15 pmRNSHolding(s) in Company
10th Sep 20213:25 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSH1 2021 Update
18th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20213:20 pmRNSResult of AGM
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
27th May 20212:06 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 202111:06 amRNSSecond Price Monitoring Extn
27th May 202111:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSAnnual Financial Report
21st May 20215:50 pmRNSNotice of Results
15th Apr 20217:00 amRNSQ1 2021 Update
1st Mar 20215:36 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSMarket Update
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
16th Dec 202011:50 amRNSGrant of Share Options
16th Oct 20207:00 amRNSQ3 2020 Update
13th Oct 20204:40 pmRNSSecond Price Monitoring Extn
13th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSINTERIM RESULTS
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:01 amRNSSecond Price Monitoring Extn
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
22nd Sep 20202:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results
19th May 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.